Curing the Incurable

代表取締役社長 兼 CEO 鈴木隆二

The immune system plays an important role in protecting our lives. Specifically, the immune cells consider foreign objects (e.g. viruses and bacteria) as enemies and attack them to remove them from our body. However, the immune system can also have unwanted aspects, such as being responsible for autoimmune diseases and allergies.

Since over a quarter of a century, researchers have focused on providing effective treatment and diagnostic methods for most of the diseases involving the immune system (e.g. infectious diseases, cancers, and autoimmune diseases). This has been done by analyzing in detail the complex immune system.

As a result, we released our unique immune diversity analysis platform simultaneously to establishing our company.
We have addressed unresolved medical issues through critical research support at research institutions such as universities and pharmaceutical companies. Additionally, we obtained Clinical research and Clinical trial support through pharmaceutical companies.

To date, we are expanding our spectrum of research in pathogenesis, diagnostics, drug discovery, and treatment. Our mission is "Curing the Incurable".
In the future, we will strive to further strengthen the pipeline of diagnostic and treatment fields.

Specifically, we are focusing on the cancer immunotherapy field. This field is rapidly accelerating both domestic and overseas research and development.
We will continue to take on the challenge in order to provide effective treatments and diagnostic methods.

President & CEO Ryuji Suzuki